Search

everythinglearnresearchcommunity

for

Search:↓

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Preventing cancer involves lifestyle changes, vaccinations, early screening, and understanding cancer's molecular basis.

Troglitazone increases subcutaneous fat in lipodystrophy patients.

Syphilis cases and re-infections increased, highlighting the need for ongoing prevention and treatment.

A young woman recovered well from rare simultaneous Hepatitis B and autoimmune hepatitis after treatment.

HHV-6 reactivation may be linked to psychiatric disorders and can improve with antiviral treatment.

Viral reactivation is rare at the time of DRESS diagnosis in the U.S.

The document concludes that reactivation of herpesviruses, especially HHV-6, is linked to severe symptoms and complications in drug-induced hypersensitivity syndrome.

Herpes simplex virus infections should be considered in pemphigus patients to avoid unnecessary changes in treatment.

The hepatitis B vaccine did not cause hair loss in the tested mice.

COVID-19 vaccination may trigger recurrence of cutaneous T-cell lymphoma in some patients.

Relapsing hepatitis A can cause prolonged abnormal liver tests even without symptoms.

Budesonide alone is less effective than standard treatment for autoimmune hepatitis.

Hepatitis B vaccination can trigger HSP, and vitamin D correction and tonsillectomy can effectively manage it.

EBV infection increases a specific keratin variant in carcinoma cells, possibly affecting cell structure and cancer progression.

A new skin cancer can develop where shingles once occurred.

The study suggests a link between varicella-zoster virus and segmental vitiligo, with evidence of the virus disrupting skin pigment cells.

A girl developed vitiligo and psoriasis after hepatitis B treatment, and stopping the treatment didn't help.

Vogt-Koyanagi-Harada disease can develop during interferon therapy for chronic hepatitis C.

Two girls experienced temporary hair loss after getting the HPV vaccine, which may be related to the vaccine.

The HPV vaccine may be linked to temporary hair loss in children, but the benefits outweigh the risks.

Autoimmune reactions may cause both alopecia areata and HAM.

RANKL improves the immune response against herpes simplex virus by enhancing T cell activation and could help develop better treatments or vaccines.

Post-COVID, many patients experience skin issues like hair loss and herpes reactivation, especially in middle-aged women.

Platelet-rich plasma therapy may rarely trigger herpes zoster ophthalmicus.

A woman experienced total hair loss after an HPV vaccine, but treatment helped regrow her hair.

Longer treatment with vismodegib lowers relapse risk in basal cell carcinoma.

BCG site reactions after COVID-19 mRNA vaccination are mild, temporary, and likely under-reported.

A rare case of a transplant patient developing a skin condition linked to HPV-49.

HTLV-1-associated lichenoid dermatitis (HALD) is linked to an immune response against HTLV-1-infected cells.